SCIENCE: Clinical assessment of dysphagia in neurodegeneration (CADN): development, validity and reliability of a bedside tool for dysphagia assessment

The CADN is a reliable, valid, brief, quantifiable, and easily deployed assessment of swallowing in neurodegenerative disease. It is thus ideally suited for both clinical bedside assessment and future multicentre clinical trials in neurodegenerative disease.

 

Click here for more details.

Tags: , , ,

Related Post

The L16HTHOUSE Study

  • Posted on 30 March, 2023
    L16HTHOUSE is a research trial testing an experimental medication for treating speech, motor, learning, and other developmental delays in children...
    Read more

    Dietary fat supplement trial for A-T

    • Posted on 30 March, 2023
      Ataxia telangiectasia (A-T) is a rare inherited condition that affects the nervous and immune systems. A-T typically impacts movement, vision...
      Read more

      Temporary Assessment of Language in Kabuki Syndrome (TALK) Study

      • Posted on 30 March, 2023
        Speech and language development is a complex, multifactorial process driven by the individual’s ability to process and formulate communication. These...
        Read more